India Grants a Compulsory Licence of Bayer's Patented Cancer Drug: The Issue of Local Working Requirement

Enrico Bonadio 

City University London - The City Law School; City University London
May 1, 2012

European Journal of Risk Regulation, Vol. 2, pp. 247-250, 2012 
Abstract:      
The article analyses the first compulsory licence granted by the Indian government. The author argues that the decision adopted by India might be in violation of the non discrimination principle enshrined in Article 27(1) TRIPS Agreement.

Number of Pages in PDF File: 4

Keywords: intellectual property, patents, pharmaceuticals, compulsory licences

Full text available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2121247